GE HealthCare Technologies Inc. $GEHC Shares Sold by Front Street Capital Management Inc.

Front Street Capital Management Inc. decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.6% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 69,938 shares of the company’s stock after selling 2,585 shares during the quarter. GE HealthCare Technologies accounts for about 1.1% of Front Street Capital Management Inc.’s investment portfolio, making the stock its 25th largest holding. Front Street Capital Management Inc.’s holdings in GE HealthCare Technologies were worth $5,645,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Petrus Trust Company LTA bought a new stake in shares of GE HealthCare Technologies in the first quarter worth $372,000. Plancorp LLC increased its stake in shares of GE HealthCare Technologies by 22.7% in the first quarter. Plancorp LLC now owns 3,843 shares of the company’s stock worth $310,000 after buying an additional 712 shares during the last quarter. Polar Asset Management Partners Inc. bought a new stake in shares of GE HealthCare Technologies in the first quarter worth $3,299,000. Nissay Asset Management Corp Japan ADV increased its stake in shares of GE HealthCare Technologies by 9.7% in the first quarter. Nissay Asset Management Corp Japan ADV now owns 113,722 shares of the company’s stock worth $9,179,000 after buying an additional 10,031 shares during the last quarter. Finally, National Wealth Management Group LLC bought a new stake in shares of GE HealthCare Technologies in the first quarter worth $672,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $75.73 on Friday. The company has a market cap of $34.58 billion, a price-to-earnings ratio of 15.52, a price-to-earnings-growth ratio of 2.89 and a beta of 1.13. The firm has a fifty day moving average of $74.28 and a 200-day moving average of $74.02. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.15. The business had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were given a $0.035 dividend. The ex-dividend date was Friday, July 25th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is 2.87%.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on GEHC shares. Zacks Research upgraded shares of GE HealthCare Technologies from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 28th. Citigroup lifted their price objective on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a “buy” rating in a report on Thursday, July 31st. Wall Street Zen raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a report on Saturday, May 31st. Morgan Stanley decreased their price objective on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an “equal weight” rating for the company in a report on Thursday, July 31st. Finally, BTIG Research reaffirmed a “buy” rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $88.55.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.